Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 4, 13

Effects of Eight Weeks of an Alleged Aromatase Inhibiting Nutritional Supplement 6-OXO (androst-4-ene-3,6,17-trione) on Serum Hormone Profiles and Clinical Safety Markers in Resistance-Trained, Eugonadal Males

Affiliations

Effects of Eight Weeks of an Alleged Aromatase Inhibiting Nutritional Supplement 6-OXO (androst-4-ene-3,6,17-trione) on Serum Hormone Profiles and Clinical Safety Markers in Resistance-Trained, Eugonadal Males

Dan Rohle et al. J Int Soc Sports Nutr.

Abstract

The purpose of this study was to determine the effects of 6-OXO, a purported nutritional aromatase inhibitor, in a dose dependent manner on body composition, serum hormone levels, and clinical safety markers in resistance trained males. Sixteen males were supplemented with either 300 mg or 600 mg of 6-OXO in a double-blind manner for eight weeks. Blood and urine samples were obtained at weeks 0, 1, 3, 8, and 11 (after a 3-week washout period). Blood samples were analyzed for total testosterone (TT), free testosterone (FT), dihydrotestosterone (DHT), estradiol, estriol, estrone, SHBG, leutinizing hormone (LH), follicle stimulating hormone (FSH), growth hormone (GH), cortisol, FT/estradiol (T/E). Blood and urine were also analyzed for clinical chemistry markers. Data were analyzed with two-way MANOVA. For all of the serum hormones, there were no significant differences between groups (p > 0.05). Compared to baseline, free testosterone underwent overall increases of 90% for 300 mg 6-OXO and 84% for 600 mg, respectively (p < 0.05). DHT underwent significant overall increases (p < 0.05) of 192% and 265% with 300 mg and 600 mg, respectively. T/E increased 53% and 67% for 300 mg and 600 mg 6-OXO, respectively. For estrone, 300 mg produced an overall increase of 22%, whereas 600 mg caused a 52% increase (p < 0.05). Body composition did not change with supplementation (p > 0.05) and clinical safety markers were not adversely affected with ingestion of either supplement dose (p > 0.05). While neither of the 6-OXO dosages appears to have any negative effects on clinical chemistry markers, supplementation at a daily dosage of 300 mg and 600 mg for eight weeks did not completely inhibit aromatase activity, yet significantly increased FT, DHT, and T/E.

Similar articles

See all similar articles

Cited by 2 PubMed Central articles

References

    1. Bhasin S, Storer T, Berman N, Yarasheski K, Clevenger B, Phillips J, Lee W, Bunnell T, Casaburi R. Testosterone replacement increases fat-free mass and muscle size in hypogonadal men. J Clin Endocrinol Metab. 1997;82:407–13. doi: 10.1210/jc.82.2.407. - DOI - PubMed
    1. Bhasin S, Storer T, Javanbakht M, Berman N, Yarasheski K, Phillips J, Dike M, Sinha-Hikim I, Shen R, Hays R, Beall G. Testosterone replacement and resistance exercise in HIV-infected men with weight loss and low testosterone levels. JAMA. 2000;283:763–70. doi: 10.1001/jama.283.6.763. - DOI - PMC - PubMed
    1. Bhasin S, Woodhouse L, Casaburi R, Singh A, Bhasin D, Berman Chen X, Yarasheski K, Magliano L, Dzekov C, Dzekov J, Bross R, Phillips J, Sinha-Hikim I, Shen R, Storer T. Testosterone dose-response relationships in healthy young men. Am J Physiol Endocrinol Metab. 2001;281:E1172–81. - PubMed
    1. Bhasin S, Woodhouse L, Storer T. Proof of the effect of testosterone on skeletal muscle. J Endocrinol. 2001;170:27–38. doi: 10.1677/joe.0.1700027. - DOI - PubMed
    1. Sinha-Hikim I, Artaza J, Woodhouse L, Gonzalez-Cadavid N, Singh A, Lee M, Storer T, Casaburi R, Shen R, Bhasin S. Testosterone-induced increase in muscle size in healthy young men is associated with muscle fiber hypertrophy. Am J Physiol Endocrinol Metab. 2002;283:E154–E164. - PubMed

LinkOut - more resources

Feedback